Assessing the Role of Immunomodulators in IBD

Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD

Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD
RestartResume

What role do immunomodulators play in the management of inflammatory bowel disorders and how should we incorporate them into our practice?

  • Overview

    With current treatment approaches in mind, how do immunomodulators fit into the therapeutic landscape for inflammatory bowel disorders, or IBD? In preparation for the 2021 Crohn’s & Colitis Congress, Dr. Charles Turck speaks with Dr. Maria Oliva-Hemker from Johns Hopkins University School of Medicine about her presentation at the event. 

Facebook Comments

Register

We’re glad to see you’re enjoying Crohn's Colitis Professional…
but how about a more personalized experience?

Register for free